1. Home
  2. LMND vs GRFS Comparison

LMND vs GRFS Comparison

Compare LMND & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lemonade Inc.

LMND

Lemonade Inc.

HOLD

Current Price

$54.80

Market Cap

4.0B

Sector

Finance

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.83

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMND
GRFS
Founded
2015
1940
Country
United States
Spain
Employees
1282
25247
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
5.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LMND
GRFS
Price
$54.80
$7.83
Analyst Decision
Hold
Hold
Analyst Count
8
2
Target Price
$60.75
$10.15
AVG Volume (30 Days)
2.6M
682.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
1.79%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$64.93
$5.33
Revenue Next Year
$32.87
$6.50
P/E Ratio
N/A
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$24.31
$6.19
52 Week High
$99.90
$11.14

Technical Indicators

Market Signals
Indicator
LMND
GRFS
Relative Strength Index (RSI) 40.75 27.72
Support Level $48.32 $7.64
Resistance Level $58.56 $9.11
Average True Range (ATR) 3.07 0.29
MACD 0.85 -0.12
Stochastic Oscillator 74.47 2.99

Price Performance

Historical Comparison
LMND
GRFS

About LMND Lemonade Inc.

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. The Company operates in one report segment providing personal property and casualty insurance products within the United States and Europe, including the UK.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: